http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 11 Jun 2026 01:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html <p> LIESTAL, Switzerland--(BUSINESS WIRE)-- <b>Curatis Holding AG (SIX: CURN) increases its revenue growth guidance for the financial year 2026: the company is forecasting a revenue growth of approximately 40% in 2026, in contrast to the previous outlook of over 25%.</b> </p><p> Based on preliminary figures for the first five months of 2026, Curatis expects a significantly higher than anticipated revenue growth for 2026. This growth is driven by products that Curatis has marketed for some time, as well as by products added to its portfolio in 2025 and 2026. Under the new guidance, Curatis projects revenues of approximately CHF 15m http://www.streetinsider.com/Press+Releases/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html Thu, 11 Jun 2026 01:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Press+Releases/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html <p> LIESTAL, Switzerland--(BUSINESS WIRE)-- <b>Curatis Holding AG (SIX: CURN) increases its revenue growth guidance for the financial year 2026: the company is forecasting a revenue growth of approximately 40% in 2026, in contrast to the previous outlook of over 25%.</b> </p><p> Based on preliminary figures for the first five months of 2026, Curatis expects a significantly higher than anticipated revenue growth for 2026. This growth is driven by products that Curatis has marketed for some time, as well as by products added to its portfolio in 2025 and 2026. Under the new guidance, Curatis projects revenues of approximately CHF 15m http://www.streetinsider.com/Press+Releases/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html Thu, 11 Jun 2026 01:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Press+Releases/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html <p> LIESTAL, Switzerland--(BUSINESS WIRE)-- <b>Curatis Holding AG (SIX: CURN) increases its revenue growth guidance for the financial year 2026: the company is forecasting a revenue growth of approximately 40% in 2026, in contrast to the previous outlook of over 25%.</b> </p><p> Based on preliminary figures for the first five months of 2026, Curatis expects a significantly higher than anticipated revenue growth for 2026. This growth is driven by products that Curatis has marketed for some time, as well as by products added to its portfolio in 2025 and 2026. Under the new guidance, Curatis projects revenues of approximately CHF 15m http://www.streetinsider.com/Press+Releases/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html Thu, 11 Jun 2026 01:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Business+Wire/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html <p> LIESTAL, Switzerland--(BUSINESS WIRE)-- <b>Curatis Holding AG (SIX: CURN) increases its revenue growth guidance for the financial year 2026: the company is forecasting a revenue growth of approximately 40% in 2026, in contrast to the previous outlook of over 25%.</b> </p><p> Based on preliminary figures for the first five months of 2026, Curatis expects a significantly higher than anticipated revenue growth for 2026. This growth is driven by products that Curatis has marketed for some time, as well as by products added to its portfolio in 2025 and 2026. Under the new guidance, Curatis projects revenues of approximately CHF 15m http://www.streetinsider.com/Business+Wire/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html Thu, 11 Jun 2026 01:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Business+Wire/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html <p> LIESTAL, Switzerland--(BUSINESS WIRE)-- <b>Curatis Holding AG (SIX: CURN) increases its revenue growth guidance for the financial year 2026: the company is forecasting a revenue growth of approximately 40% in 2026, in contrast to the previous outlook of over 25%.</b> </p><p> Based on preliminary figures for the first five months of 2026, Curatis expects a significantly higher than anticipated revenue growth for 2026. This growth is driven by products that Curatis has marketed for some time, as well as by products added to its portfolio in 2025 and 2026. Under the new guidance, Curatis projects revenues of approximately CHF 15m http://www.streetinsider.com/Business+Wire/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html Thu, 11 Jun 2026 01:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Business+Wire/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html <p> LIESTAL, Switzerland--(BUSINESS WIRE)-- <b>Curatis Holding AG (SIX: CURN) increases its revenue growth guidance for the financial year 2026: the company is forecasting a revenue growth of approximately 40% in 2026, in contrast to the previous outlook of over 25%.</b> </p><p> Based on preliminary figures for the first five months of 2026, Curatis expects a significantly higher than anticipated revenue growth for 2026. This growth is driven by products that Curatis has marketed for some time, as well as by products added to its portfolio in 2025 and 2026. Under the new guidance, Curatis projects revenues of approximately CHF 15m http://www.streetinsider.com/Business+Wire/Curatis+Increases+Revenue+Growth+Guidance+for+2026/26631491.html Thu, 11 Jun 2026 01:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Earnings/Currency+Exchange+International%2C+Corp.+%28CURN%29+Reports+Q2+EPS+of+%240.40/26624806.html <p>Currency Exchange International, Corp. (OTC: CURN) reported Q2 EPS of $0.40.Revenue for the quarter came in at $18 million.</p><p>For earnings history and earnings-related data on Currency Exchange International, Corp. (CURN) <a href="http://www.streetinsider.com/ec_earnings.php?q=CURN">click here</a>.</p> http://www.streetinsider.com/Earnings/Currency+Exchange+International%2C+Corp.+%28CURN%29+Reports+Q2+EPS+of+%240.40/26624806.html Tue, 09 Jun 2026 17:18:23 -0400 CURN http://www.streetinsider.com/Earnings/Currency+Exchange+International%2C+Corp.+%28CURN%29+Reports+Q1+EPS+of+%240.32/26148020.html <p>Currency Exchange International, Corp. (OTC: CURN) reported Q1 EPS of $0.32. Revenue for the quarter came in at $15.4 million.</p><p>For earnings history and earnings-related data on Currency Exchange International, Corp. (CURN) <a href="http://www.streetinsider.com/ec_earnings.php?q=CURN">click here</a>.</p> http://www.streetinsider.com/Earnings/Currency+Exchange+International%2C+Corp.+%28CURN%29+Reports+Q1+EPS+of+%240.32/26148020.html Thu, 12 Mar 2026 02:34:09 -0400 CURN http://www.streetinsider.com/Press+Releases/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html <ul class="bwlistdisc"> <li> Japan is one of the world&apos;s most important pharmaceutical markets after the US and Europe. </li> <li> Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. </li> <li> The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. </li> <li> The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually. </li> </ul> <p> LIESTAL, http://www.streetinsider.com/Press+Releases/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html Wed, 11 Mar 2026 02:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Press+Releases/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html <ul class="bwlistdisc"> <li> Japan is one of the world&apos;s most important pharmaceutical markets after the US and Europe. </li> <li> Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. </li> <li> The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. </li> <li> The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually. </li> </ul> <p> LIESTAL, http://www.streetinsider.com/Press+Releases/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html Wed, 11 Mar 2026 02:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Press+Releases/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html <ul class="bwlistdisc"> <li> Japan is one of the world&apos;s most important pharmaceutical markets after the US and Europe. </li> <li> Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. </li> <li> The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. </li> <li> The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually. </li> </ul> <p> LIESTAL, http://www.streetinsider.com/Press+Releases/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html Wed, 11 Mar 2026 02:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Business+Wire/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html <ul class="bwlistdisc"> <li> Japan is one of the world&apos;s most important pharmaceutical markets after the US and Europe. </li> <li> Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. </li> <li> The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. </li> <li> The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually. </li> </ul> <p> LIESTAL, http://www.streetinsider.com/Business+Wire/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html Wed, 11 Mar 2026 02:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Business+Wire/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html <ul class="bwlistdisc"> <li> Japan is one of the world&apos;s most important pharmaceutical markets after the US and Europe. </li> <li> Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. </li> <li> The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. </li> <li> The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually. </li> </ul> <p> LIESTAL, http://www.streetinsider.com/Business+Wire/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html Wed, 11 Mar 2026 02:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Business+Wire/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html <ul class="bwlistdisc"> <li> Japan is one of the world&apos;s most important pharmaceutical markets after the US and Europe. </li> <li> Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. </li> <li> The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. </li> <li> The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually. </li> </ul> <p> LIESTAL, http://www.streetinsider.com/Business+Wire/Curatis+and+Neupharma+Announce+Exclusive+Licensing+Agreement+to+Develop+and+Market+Corticorelin+%28C-PTBE-01%29+for+the+Treatment+of+Peritumoral+Brain+Edema+in+Japan/26141597.html Wed, 11 Mar 2026 02:00:00 -0400 CURN KNRS O.00222576 http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+renews+share+buyback+program+for+up+to+359%2C617+shares/25668000.html <p>Currency Exchange International Corp. (TSX: CXI) (OTCQX: CURN) announced the Toronto Stock Exchange has accepted its notice to renew its normal course issuer bid and automatic securities purchase plan. The program allows the company to repurchase up to 359,617 common shares for cancellation, representing 10% of its public float as of November 18, 2025.</p> <p>The company had 6,134,120 common shares outstanding as of November 18, 2025. Share purchases may begin December 2, 2025, and will terminate December 1, 2026, or earlier if the maximum number of shares is repurchased.</p> <p>Currency Exchange will purchase shares on the open market through TSX facilities and http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+renews+share+buyback+program+for+up+to+359%2C617+shares/25668000.html Wed, 26 Nov 2025 10:46:48 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+renews+share+buyback+program+for+up+to+359%2C617+shares/25668000.html <p>Currency Exchange International Corp. (TSX: CXI) (OTCQX: CURN) announced the Toronto Stock Exchange has accepted its notice to renew its normal course issuer bid and automatic securities purchase plan. The program allows the company to repurchase up to 359,617 common shares for cancellation, representing 10% of its public float as of November 18, 2025.</p> <p>The company had 6,134,120 common shares outstanding as of November 18, 2025. Share purchases may begin December 2, 2025, and will terminate December 1, 2026, or earlier if the maximum number of shares is repurchased.</p> <p>Currency Exchange will purchase shares on the open market through TSX facilities and http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+renews+share+buyback+program+for+up+to+359%2C617+shares/25668000.html Wed, 26 Nov 2025 10:46:48 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+renews+share+buyback+program+for+up+to+359%2C617+shares/25668000.html <p>Currency Exchange International Corp. (TSX: CXI) (OTCQX: CURN) announced the Toronto Stock Exchange has accepted its notice to renew its normal course issuer bid and automatic securities purchase plan. The program allows the company to repurchase up to 359,617 common shares for cancellation, representing 10% of its public float as of November 18, 2025.</p> <p>The company had 6,134,120 common shares outstanding as of November 18, 2025. Share purchases may begin December 2, 2025, and will terminate December 1, 2026, or earlier if the maximum number of shares is repurchased.</p> <p>Currency Exchange will purchase shares on the open market through TSX facilities and http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+renews+share+buyback+program+for+up+to+359%2C617+shares/25668000.html Wed, 26 Nov 2025 10:46:48 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Press+Releases/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html <p align="justify">TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Currency Exchange International, Corp.<strong> (“Currency Exchange” or the “Company”) (TSX:CXI) (OTCQX:CURN) </strong>announced today a correction to its news release issued earlier today entitled “Currency Exchange International, Corp. Announces Renewal of Share Buyback Program and Automatic Securities Purchase Plan.” This news release is being republished to correct an error in the average daily traded volume in the initial news release. The complete, corrected news release follows:</p> <p align="justify">Currency Exchange International, Corp. today announced acceptance by the Toronto Stock Exchange (the &quot;<strong>TSX</strong>&quot;) of Currency Exchange’s Notice of Intention to renew its http://www.streetinsider.com/Press+Releases/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html Wed, 26 Nov 2025 10:46:00 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Press+Releases/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html <p align="justify">TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Currency Exchange International, Corp.<strong> (“Currency Exchange” or the “Company”) (TSX:CXI) (OTCQX:CURN) </strong>announced today a correction to its news release issued earlier today entitled “Currency Exchange International, Corp. Announces Renewal of Share Buyback Program and Automatic Securities Purchase Plan.” This news release is being republished to correct an error in the average daily traded volume in the initial news release. The complete, corrected news release follows:</p> <p align="justify">Currency Exchange International, Corp. today announced acceptance by the Toronto Stock Exchange (the &quot;<strong>TSX</strong>&quot;) of Currency Exchange’s Notice of Intention to renew its http://www.streetinsider.com/Press+Releases/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html Wed, 26 Nov 2025 10:46:00 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Press+Releases/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html <p align="justify">TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Currency Exchange International, Corp.<strong> (“Currency Exchange” or the “Company”) (TSX:CXI) (OTCQX:CURN) </strong>announced today a correction to its news release issued earlier today entitled “Currency Exchange International, Corp. Announces Renewal of Share Buyback Program and Automatic Securities Purchase Plan.” This news release is being republished to correct an error in the average daily traded volume in the initial news release. The complete, corrected news release follows:</p> <p align="justify">Currency Exchange International, Corp. today announced acceptance by the Toronto Stock Exchange (the &quot;<strong>TSX</strong>&quot;) of Currency Exchange’s Notice of Intention to renew its http://www.streetinsider.com/Press+Releases/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html Wed, 26 Nov 2025 10:46:00 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Globe+Newswire/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html <p align="justify">TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Currency Exchange International, Corp.<strong> (“Currency Exchange” or the “Company”) (TSX:CXI) (OTCQX:CURN) </strong>announced today a correction to its news release issued earlier today entitled “Currency Exchange International, Corp. Announces Renewal of Share Buyback Program and Automatic Securities Purchase Plan.” This news release is being republished to correct an error in the average daily traded volume in the initial news release. The complete, corrected news release follows:</p> <p align="justify">Currency Exchange International, Corp. today announced acceptance by the Toronto Stock Exchange (the &quot;<strong>TSX</strong>&quot;) of Currency Exchange’s Notice of Intention to renew its http://www.streetinsider.com/Globe+Newswire/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html Wed, 26 Nov 2025 10:46:00 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Globe+Newswire/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html <p align="justify">TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Currency Exchange International, Corp.<strong> (“Currency Exchange” or the “Company”) (TSX:CXI) (OTCQX:CURN) </strong>announced today a correction to its news release issued earlier today entitled “Currency Exchange International, Corp. Announces Renewal of Share Buyback Program and Automatic Securities Purchase Plan.” This news release is being republished to correct an error in the average daily traded volume in the initial news release. The complete, corrected news release follows:</p> <p align="justify">Currency Exchange International, Corp. today announced acceptance by the Toronto Stock Exchange (the &quot;<strong>TSX</strong>&quot;) of Currency Exchange’s Notice of Intention to renew its http://www.streetinsider.com/Globe+Newswire/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html Wed, 26 Nov 2025 10:46:00 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Globe+Newswire/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html <p align="justify">TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Currency Exchange International, Corp.<strong> (“Currency Exchange” or the “Company”) (TSX:CXI) (OTCQX:CURN) </strong>announced today a correction to its news release issued earlier today entitled “Currency Exchange International, Corp. Announces Renewal of Share Buyback Program and Automatic Securities Purchase Plan.” This news release is being republished to correct an error in the average daily traded volume in the initial news release. The complete, corrected news release follows:</p> <p align="justify">Currency Exchange International, Corp. today announced acceptance by the Toronto Stock Exchange (the &quot;<strong>TSX</strong>&quot;) of Currency Exchange’s Notice of Intention to renew its http://www.streetinsider.com/Globe+Newswire/Correction+to+Currency+Exchange+International%2C+Corp.+Announcement+of+Renewal+of+Share+Buyback+Program+and+Automatic+Securities+Purchase+Plan/25667997.html Wed, 26 Nov 2025 10:46:00 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+International+renews+share+buyback+program/25666238.html <p>Currency Exchange International Corp. (TSX: CXI) (OTCQX: CURN) announced that the Toronto Stock Exchange has accepted its notice to renew its normal course issuer bid and automatic securities purchase plan. The program allows the company to repurchase up to 359,617 common shares for cancellation, representing 10% of its public float as of November 18, 2025.</p> <p>The company had 6,134,120 common shares outstanding as of November 18, 2025. Share purchases may begin December 2, 2025 and will terminate on December 1, 2026, or earlier if the maximum number of shares is reached.</p> <p>Currency Exchange will purchase shares on the open market through TSX http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+International+renews+share+buyback+program/25666238.html Wed, 26 Nov 2025 07:01:45 -0400 CURN CXI O.04748594 http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+International+renews+share+buyback+program/25666238.html <p>Currency Exchange International Corp. (TSX: CXI) (OTCQX: CURN) announced that the Toronto Stock Exchange has accepted its notice to renew its normal course issuer bid and automatic securities purchase plan. The program allows the company to repurchase up to 359,617 common shares for cancellation, representing 10% of its public float as of November 18, 2025.</p> <p>The company had 6,134,120 common shares outstanding as of November 18, 2025. Share purchases may begin December 2, 2025 and will terminate on December 1, 2026, or earlier if the maximum number of shares is reached.</p> <p>Currency Exchange will purchase shares on the open market through TSX http://www.streetinsider.com/Stock+Buybacks/Currency+Exchange+International+renews+share+buyback+program/25666238.html Wed, 26 Nov 2025 07:01:45 -0400 CURN CXI O.04748594